Literature DB >> 22805281

Current differential diagnoses and treatment options of vascular occlusions presenting as bilateral thalamic infarcts: a review of the literature.

Nitin Agarwal1, Arpan Tolia, David Richard Hansberry, Ennis Jesus Duffis, James C Barrese, Chirag D Gandhi, Charles J Prestigiacomo.   

Abstract

bilateral thalamic infarctions are rare and usually caused by vascular occlusions. When symptomatic, it is important to make a distinction between different vascular etiologies in order to provide an effective and timely therapeutic response. Clinical presentations may not adequately differentiate between the vascular etiologies alone. It is therefore important to use imaging technologies to distinguish appropriately the origin of the infarct so that proper treatment can be administered. Advanced imaging techniques, such as CT angiography and MR angiography, have proved useful for distinguishing between arterial and venous causes of bithalamic infarctions. Bilateral thalamic venous infarctions can be treated with anticoagulation medication and with thrombolysis in more severe cases. Bilateral thalamic arterial infarctions may be treated with thrombolysis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22805281     DOI: 10.1136/neurintsurg-2012-010352

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  3 in total

1.  Direct Growth of Carbon Nanotubes on New High-Density 3D Pyramid-Shaped Microelectrode Arrays for Brain-Machine Interfaces.

Authors:  Bahareh Ghane Motlagh; May Choueib; Alireza Hajhosseini Mesgar; Md Hasanuzzaman; Mohamad Sawan
Journal:  Micromachines (Basel)       Date:  2016-09-08       Impact factor: 2.891

2.  Artery of Percheron infarction a rare anatomical variant and a diagnostic challenge: Case report.

Authors:  Osama Abdalla Mabrouk Kheiralla
Journal:  Radiol Case Rep       Date:  2020-10-28

3.  A Case of Midbrain and Thalamic Infarction Involving Artery of Percheron.

Authors:  Muhammad Almamun; Appu Suman; Syed Arshad; Sonni Jayathirthachar Sanjeev Kumar
Journal:  J Clin Med       Date:  2015-03-03       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.